Bioharvest Sciences Inc.
- Last sale
- Nov 12, 2026
- Market cap
- $39.67M
- 22.67M shares
- Filings
- 137
FY 2025+37.0% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
—
—
—FY 2025+863.4% FY25 yoy
- $39.67M
- —
- 1.1×
- 1.6×
- -24.15%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $34,508,000 | reported | |
| FY 2024 | 2024-12-31 | $25,188,000 | reported | |
| FY 2023 | 2023-12-31 | $12,672,000 | reported |
Segments
Segments
LineFY2025ShareChange
Products$32.63M95%+31.0%
North America$30.59M89%+32.9%
Israel$3.92M11%+80.2%
CDMO Services$1.88M5.4%+566.0%
Total$34.51M
Pharmaceutical preparations
Bioharvest Sciences Inc. is the 143rd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BGMBGM Group Ltd.$37.9M51.1%52.6%—LIFDLFTD Partners Inc.$36.9M1.1%67.3%$3.7MSBFMSunshine Biopharma Inc.$36.3M4.1%16.5%$2.4METSTEarth Science Tech, Inc.$35.7M7.8%10.2%$25.8MVRCAVerrica Pharmaceuticals Inc.$35.6M370.2%50.3%$52.9M
BHSTBioharvest Sciences Inc. (this company)$34.5M37.0%32.3%$39.7M
ZOMDFZomedica Corp.$32.0M17.4%255.6%$78.4MVSTMVerastem, Inc.$30.9M209.1%677.6%$1.1BFHTXFoghorn Therapeutics Inc.$30.9M36.8%240.3%$123.5MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Bioharvest Sciences Inc. · CIK 1723464 · Engraved from SEC EDGAR